Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Dr. Michael presents new research on the potential efficacy of ketamine’s metabolite hydroxynorketamine for opioid addiction

No Comments
| News

Dr. Michael (Marie Curie fellow from our lab) presented new research at the Mediterranean Neuroscience Society Conference in Crete, showcasing our latest findings on how a ketamine metabolite could help treat opioid addiction. Her poster focused on (2R,6R)-hydroxynorketamine (HNK), a ketamine metabolite, and its effects on opioid addiction-related behaviors in mice. The research tackled one […]

Read More »

Dr. Zanos discusses social media’s impact on the brain at Pan-Cypriot Festival of Youth and Students event

No Comments
| News

Dr. Panos Zanos delivered an engaging discussion on “Social Media & Brain” as part of the 37th Pan-Cypriot Festival of Youth and Students. The talk explored the fascinating intersection between our digital habits and neurological processes, including insights from current research on how social media platforms influence brain function, potentially covering topics such as dopamine reward […]

Read More »

Dr. Polymnia Louka’s inspiring talk at the European University Cyprus annual conference

No Comments
| News

The Zanos Lab is delighted to share that Dr. Polymnia Louka, our Marie Skłodowska-Curie Fellow, delivered an engaging talk at the European University Cyprus (EUC) Annual Conference. Invited to address students and faculty, Dr. Louka discussed her journey to securing the prestigious and competitive Marie Curie Fellowship, as well as her innovative research exploring the […]

Read More »

Zanos Lab part of the newly-awarded European COST action “PSY-NET” (Psychedelic renaissance)

No Comments
| News

We are pleased to announce that the Zanos Lab at the University of Cyprus is an integral part of the newly awarded COST Action “PSY-NET: Psychedelic renaissance: turn on, tune in and drop in” (OC-2024-1-27517). This collaborative network brings together 83 leading researchers from 21 European countries to advance psychedelic research across multiple disciplines. The […]

Read More »

Zanos Lab research on biomarkers of nicotine addiction relapse presented at the Hellenic Psychological Society conference

No Comments
| News

The Zanos Lab is pleased to announce that Dr. Apostolakis has presented research at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” addressed a critical challenge in smoking cessation efforts. Nicotine addiction is characterized by high […]

Read More »

Dr. Zanos presented groundbreaking ketamine research at University of Bern’s Neuroscience lecture series

No Comments
| News

We are pleased to announce that Dr. Panos Zanos, Director of the Zanos Lab at the University of Cyprus, recently delivered a lecture as part of the prestigious Neuroscience Lecture Series (NLS) at the University of Bern, Switzerland, for the 2024/25 academic year. Dr. Zanos presented the lab’s cutting-edge research on ketamine’s antidepressant properties, challenging […]

Read More »

Zanos Lab research decodes molecular pathways in Opioid Use Disorder and Depression at Hellenic Psychological Society conference

No Comments
| News

Dr. Zanos has presented new research of our lab at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Decoding common molecular pathways affected in opioid use disorder and depression,” explored the complex relationship between these frequently co-occurring conditions. This research was led by our lab members, Drs. Anna Onisiforou and Andrea […]

Read More »

Our postdoctoral fellow, Dr. Andria Michael, presents at YUFE4Postdocs workshop in University of Antwerp

No Comments
| News

We are pleased to announce that our postdoctoral researcher, Dr. Andria Michael, recently participated in the YUFE4Postdocs training workshop hosted at the University of Antwerp. The workshop focused on stakeholder interaction and open science practices, bringing together talented postdoctoral researchers from across the YUFE alliance. During this spring workshop, Dr. Michael had the opportunity to […]

Read More »

Zanos Lab postdoctoral researcher Dr. Polymnia Louka contributes expert article on depression and bone health

No Comments
| News

We are pleased to announce that Dr. Polymnia Louka of the Zanos Laboratory recently authored an informative article in a prominent Cypriot newspaper addressing the important relationship between depression and bone health. In her article, Dr. Louka explains that depression is one of the most common psychiatric disorders in the modern world, affecting approximately 5% […]

Read More »

Zanos Lab Awarded $100,000 IDSA Foundation Grant for Alzheimer’s Research

No Comments
| News

We are pleased to announce that Dr. Anna Onisiforou and Dr. Zanos  have been awarded a $100,000 grant from the Infectious Diseases Society of America (IDSA) Foundation. The grant will support an innovative project entitled “Sex-Specific Mechanisms of HSV-1 and EBV in Alzheimer’s Disease Risk.” This competitive funding was awarded through the 2025 Microbial Pathogenesis […]

Read More »

Posts pagination

Previous 1 … 4 5 6 … 13 Next

Recent Posts

  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026
  • Research spotlight: Alexithymia and emotion regulation across smoking status groups May 26, 2026
  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026
  • New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis February 24, 2026
  • New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms January 29, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress